Aziz Mottiwala, Chief Commercial Officer at Tarsus Pharmaceuticals, Inc. (TARS), sold 697 shares at $12.61 ($9K) on 2023-03-20, disclosed to the SEC on 2023-03-21.
Open-market sale of $9k TARS by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $13.28 | 339 | $5K | 49.9% |
| 2 | $12.61 | 358 | $5K | 50.1% |
| Total | $12.94 avg | 697 | $9K | 100% |
| Filing → |
| TARS | SELL | 2025-03-20 | $1.0M | — | Filing → |
| TARS | SELL | 2024-03-19 | $292K | — | Filing → |
| TARS | SELL | 2023-07-21 | $48K | — | Filing → |